Binimetinib Impurity 11 | CAS 391212-30-9 - Request Quote
Binimetinib Impurity 11
| SZ CAT No: | SZ-B053017 |
| CAS No | 391212-30-9 |
| Mol.F. | C12H11NO4 |
| Mol.Wt. | 233.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Binimetinib Impurity 11 is chemically 2-(2-(Vinyloxy)ethoxy)isoindoline-1,3-dione. Binimetinib Impurity 11 is supplied with detailed characterization data compliant with regulatory guideline. Binimetinib Impurity 11 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Binimetinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 391212-30-9
Purchase 391212-30-9
Order 391212-30-9
Enquire 391212-30-9
price of 391212-30-9
391212-30-9 Supplier
391212-30-9 Manufacturer
391212-30-9 Exporter
buy high quality Binimetinib Impurity 11
Purchase Binimetinib Impurity 11
Binimetinib Impurity 11 suppliers
Binimetinib Impurity 11 manufacturers
Binimetinib Impurity 11 price
Order Binimetinib Impurity 11
Enquire Binimetinib Impurity 11
Binimetinib Impurity 11 cost
Binimetinib Impurity 11 Supplier
Binimetinib Impurity 11 Distributor
Binimetinib Impurity 11 for Method Validation
Binimetinib Reference Standard
Binimetinib Impurity 11 for ANDA Filing
Binimetinib Impurity 11 for Forced Degradation Studies
Binimetinib Impurity 11 Identification Standards
Binimetinib Impurity 11 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


